JP2017530185A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530185A5
JP2017530185A5 JP2017518989A JP2017518989A JP2017530185A5 JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5 JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5
Authority
JP
Japan
Prior art keywords
methyl
dichlorophenyl
dihydroisoquinolin
ethanone
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518989A
Other languages
English (en)
Japanese (ja)
Other versions
JP6622299B2 (ja
JP2017530185A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073053 external-priority patent/WO2016055479A1/en
Publication of JP2017530185A publication Critical patent/JP2017530185A/ja
Publication of JP2017530185A5 publication Critical patent/JP2017530185A5/ja
Application granted granted Critical
Publication of JP6622299B2 publication Critical patent/JP6622299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518989A 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体 Active JP6622299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188174.8 2014-10-08
EP14188174 2014-10-08
PCT/EP2015/073053 WO2016055479A1 (en) 2014-10-08 2015-10-06 Tetrahydroisoquinoline derivatives

Publications (3)

Publication Number Publication Date
JP2017530185A JP2017530185A (ja) 2017-10-12
JP2017530185A5 true JP2017530185A5 (enExample) 2019-10-03
JP6622299B2 JP6622299B2 (ja) 2019-12-18

Family

ID=51790569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518989A Active JP6622299B2 (ja) 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体

Country Status (18)

Country Link
US (1) US10105359B2 (enExample)
EP (1) EP3204359B1 (enExample)
JP (1) JP6622299B2 (enExample)
CN (1) CN107001278B (enExample)
BR (1) BR112017007123B1 (enExample)
CA (1) CA2963951C (enExample)
CY (1) CY1123417T1 (enExample)
DK (1) DK3204359T3 (enExample)
EA (1) EA035544B1 (enExample)
ES (1) ES2821821T3 (enExample)
HR (1) HRP20201469T1 (enExample)
HU (1) HUE050664T2 (enExample)
LT (1) LT3204359T (enExample)
PL (1) PL3204359T3 (enExample)
PT (1) PT3204359T (enExample)
RS (1) RS60933B1 (enExample)
SI (1) SI3204359T1 (enExample)
WO (1) WO2016055479A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108884077A (zh) * 2016-02-25 2018-11-23 阿森纽荣股份公司 糖苷酶抑制剂
CN108884050B (zh) 2016-04-13 2022-07-05 Ucb生物制药私人有限公司 四氢异喹啉衍生物
CN107698433A (zh) * 2017-09-12 2018-02-16 潍坊滨海石油化工有限公司 苯乙酸的制备方法
ES2899679T3 (es) 2017-12-01 2022-03-14 UCB Biopharma SRL Agentes de formación de imágenes
TWI725408B (zh) * 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
MX2021015872A (es) * 2019-07-01 2022-02-03 UCB Biopharma SRL Un derivado de tetrahidroisoquinolina sustituido como modulador alosterico positivo de d1.
PH12021552825A1 (en) * 2019-07-01 2022-10-03 UCB Biopharma SRL A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator
US20230255934A1 (en) * 2020-04-24 2023-08-17 The Regents Of The University Of California Nurr1 receptor modulators and uses thereof
CN111943930B (zh) * 2020-08-25 2022-11-01 南京三元阳普医药科技有限公司 Lasmiditan的合成工艺
EP4200280B1 (en) * 2020-10-07 2024-02-21 Eli Lilly And Company Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1 receptor positive allosteric modulators
EP4267555A1 (en) 2020-12-03 2023-11-01 UCB Biopharma SRL Octahydroisoquinolinyl derivatives
ES3004257T3 (en) * 2020-12-18 2025-03-12 UCB Biopharma SRL Prodrugs of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone
CA3202106A1 (en) 2020-12-18 2022-06-23 Adrian Hall Dihydroisoquinolinyl derivatives
CN116685308A (zh) * 2020-12-18 2023-09-01 Ucb生物制药有限责任公司 无定形固体分散体
SI4263517T1 (sl) * 2020-12-18 2025-01-31 UCB Biopharma SRL Substituiran tetrahidroizokinolinski derivat kot pozitivni alosterični modulator d1
US20240299375A1 (en) 2021-03-08 2024-09-12 Eli Lilly And Company Use of mevidalen and other d1 positive allosteric modulators in the treatment of hallucinations and dementia-related psychosis
CN117337173A (zh) 2021-03-09 2024-01-02 伊莱利利公司 美维达林和其他d1正向别构调节剂用于减缓帕金森氏病进展的用途
CN114671810B (zh) * 2022-03-21 2024-03-22 济南鸿湾生物技术有限公司 一种咪唑苯脲的制备方法
CN115611768B (zh) * 2022-11-14 2024-03-05 郑州大学 一种3,4-二氯苯腈的合成方法
CN118724764B (zh) * 2024-06-07 2025-11-18 绍兴文理学院 一种芳基伯磺酰胺类化合物的制备方法
CN119569653B (zh) * 2024-11-25 2026-04-14 滁州市庆云医药有限公司 一种罗沙司他中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
AU2002351733A1 (en) * 2001-12-19 2003-06-30 H. Lundbeck A/S 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
ES2342083T3 (es) * 2004-04-29 2010-07-01 Aventis Pharmaceuticals Inc. 3-piperidinilisocroman-5-oles como agonistas de dopamina.
JP2010520217A (ja) * 2007-03-01 2010-06-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンh3受容体のモジュレーターとしてのテトラヒドロイソキノリン化合物

Similar Documents

Publication Publication Date Title
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2016517878A5 (enExample)
RU2606497C2 (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
ES2629414T3 (es) Derivados de tiazol
JP2021500345A5 (enExample)
JP2020506946A5 (enExample)
RU2018140092A (ru) Новые пиразолпиримидиновые производные
RU2018123779A (ru) Новые соединения
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
JP2014506599A5 (enExample)
JP2010510319A5 (enExample)
JP2016523911A5 (enExample)
JP2017503837A5 (enExample)
JP2017511794A5 (enExample)
JP2019513776A5 (enExample)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2014526549A5 (enExample)
JP2019504009A5 (enExample)
JP2019508384A (ja) 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
HRP20191821T1 (hr) Antiproliferativni spojevi i načini njihove uporabe
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
HRP20171670T1 (hr) Spojevi i sastavi za moduliranje egfr-aktiviteta
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
RU2015111133A (ru) Ингибиторы тирозинкиназы брутона
JP2017532360A5 (enExample)